Basics Akero Therapeutics, Inc. IPO Date: July 17, 2019 Sector: Healthcare Industry: Biotech Market Cap: $4.31B Activated in VL: True Average Daily Range Avg Daily Range: $0.77 | 2.81% Avg Daily Range (30 D): $0.53 | 1.14% Avg Daily Range (90 D): $0.75 | 1.51% Institutional Daily Volume Avg Daily Volume: .58M Avg Daily Volume (30 D): 2.79M Avg Daily Volume (90 D): 1.49M Trade Size Avg Trade Size (Sh.): 66 Avg Trade Size (Sh.) (30 D): 114 Avg Trade Size (Sh.) (90 D): 76 Institutional Trades Total Inst.Trades: 2,940 Avg Inst. Trade: $2.88M Avg Inst. Trade (30 D): $3.63M Avg Inst. Trade (90 D): $4.32M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $4.29M Avg Closing Trade (30 D): $9.68M Avg Closing Trade (90 D): $9.5M Avg Closing Volume: 124.95K     News Oct 17, 2025 @ 1:11 AM SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investi... Source: Halper Sadeh Llc Oct 16, 2025 @ 8:51 PM BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Inve... Source: Brodsky & Smith Oct 16, 2025 @ 3:13 PM Novo Nordisk Stock Seen Undervalued Despite Pullba... Source: Chris Markoch Oct 10, 2025 @ 9:30 PM $HAREHOLDER ALERT: The M&A Class Action Firm Annou... Source: Juan Monteverde Oct 9, 2025 @ 4:00 PM SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investi... Source: Halper Sadeh Llc Financials   TTM Q2 2025 Q1 2025 Basic EPS $-3.8 $-.86 $-.9 Diluted EPS $-3.8 $-.86 $-.9 Revenue $ $ $ Gross Profit $ $ $ Net Income / Loss $ -283.96M $ -70.51M $ -70.73M Operating Income / Loss $ -321.48M $ -80.87M $ -80.88M Cost of Revenue $ $ $ Net Cash Flow $ -89.91M $ 34.53M $ -154.32M PE Ratio